144 related articles for article (PubMed ID: 18323543)
1. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
Bear HD
J Clin Oncol; 2008 Mar; 26(8):1195-7. PubMed ID: 18323543
[No Abstract] [Full Text] [Related]
2. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
Pachmann K; Camara O; Kavallaris A; Krauspe S; Malarski N; Gajda M; Kroll T; Jörke C; Hammer U; Altendorf-Hofmann A; Rabenstein C; Pachmann U; Runnebaum I; Höffken K
J Clin Oncol; 2008 Mar; 26(8):1208-15. PubMed ID: 18323545
[TBL] [Abstract][Full Text] [Related]
3. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in breast cancer: fiction or reality?
Cristofanilli M; Reuben J; Uhr J
J Clin Oncol; 2008 Jul; 26(21):3656-7; author reply 3657-8. PubMed ID: 18640950
[No Abstract] [Full Text] [Related]
5. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
7. Longtime recirculating tumor cells in breast cancer patients.
Pachmann K
Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
[No Abstract] [Full Text] [Related]
8. The prognostic implications of circulating tumor cells in patients with breast cancer.
Smerage JB; Hayes DF
Cancer Invest; 2008 Mar; 26(2):109-14. PubMed ID: 18259939
[No Abstract] [Full Text] [Related]
9. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
[No Abstract] [Full Text] [Related]
11. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
13. [Search for tumor cells in the venous blood in relation to postoperative care of cancer patients].
Peckholz I; Melchert R
Zentralbl Chir; 1966 Sep; 91(36):1313-7. PubMed ID: 5995396
[No Abstract] [Full Text] [Related]
14. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
Hanisch E; Hottenrott C; Roukos DH
Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
[No Abstract] [Full Text] [Related]
15. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
Dixon JM
Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
[TBL] [Abstract][Full Text] [Related]
16. Circulating and disseminated tumor cells.
Braun S; Naume B
J Clin Oncol; 2005 Mar; 23(8):1623-6. PubMed ID: 15755968
[No Abstract] [Full Text] [Related]
17. [Apropos of the long-term evolution of operated breast cancer. Recurrence or new tumor?].
Jallut O
Oncology; 1966; 20():Suppl:37-44. PubMed ID: 5926983
[No Abstract] [Full Text] [Related]
18. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
van Nes JG; Putter H; Julien JP; Tubiana-Hulin M; van de Vijver M; Bogaerts J; de Vos M; van de Velde CJ;
Breast Cancer Res Treat; 2009 May; 115(1):101-13. PubMed ID: 18484198
[TBL] [Abstract][Full Text] [Related]
19. Molecular prediction of recurrence of breast cancer.
Tanvetyanon T
N Engl J Med; 2005 Apr; 352(15):1605-7; author reply 1605-7. PubMed ID: 15832454
[No Abstract] [Full Text] [Related]
20. Breast cancer in the elderly.
Thomas GA; Leonard RC
Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):79-80. PubMed ID: 19071001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
